HAP Trading’s Amicus Therapeutics FOLD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-23,000
Closed -$14K 1647
2022
Q3
$14K Buy
23,000
+9,700
+73% +$108K ﹤0.01% 1242
2022
Q2
$7K Buy
13,300
+700
+6% +$5.76K ﹤0.01% 1549
2022
Q1
$6K Buy
12,600
+2,200
+21% +$20.6K ﹤0.01% 1901
2021
Q4
$4K Sell
10,400
-5,000
-32% -$55.7K ﹤0.01% 2271
2021
Q3
$5K Sell
15,400
-6,400
-29% -$65.5K ﹤0.01% 2168
2021
Q2
$6K Sell
21,800
-1,100
-5% -$10.7K ﹤0.01% 2102
2021
Q1
$6K Buy
22,900
+12,300
+116% +$190K ﹤0.01% 1723
2020
Q4
$70K Buy
+10,600
New +$217K ﹤0.01% 1297
2019
Q4
Sell
-14,000
Closed -$5K 1314
2019
Q3
$5K Buy
+14,000
New +$152K ﹤0.01% 1120
2019
Q2
Sell
-37,100
Closed -$38K 1203
2019
Q1
$38K Buy
37,100
+25,300
+214% +$309K ﹤0.01% 718
2018
Q4
$5K Buy
+11,800
New +$130K ﹤0.01% 1013
2018
Q3
Sell
-19,800
Closed -$8K 1056
2018
Q2
$8K Sell
19,800
-25,200
-56% -$381K ﹤0.01% 888
2018
Q1
$8K Sell
45,000
-100
-0.2% -$1.52K ﹤0.01% 832
2017
Q4
$25K Buy
+45,100
New +$620K ﹤0.01% 763
2015
Q1
Sell
-314,500
Closed -$967K 1029
2014
Q4
$967K Hold
314,500
0.04% 327
2014
Q3
$495K Hold
314,500
0.02% 470
2014
Q2
$204K Buy
+314,500
New +$738K 0.01% 576

Other funds holding FOLD

HAP Trading's FOLD Position: Q4 2021 in Review

HAP Trading sold out of Amicus Therapeutics (FOLD) in Q4 2021, closing a stake of 26,527 shares — an estimated $296K sold.

HAP Trading first reported a position in FOLD in Q1 2017 and held it in 5 quarters. The position peaked at $1.18M in Q4 2020. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2021.

  • HAP Trading reported no remaining Amicus Therapeutics position as of Q4 2021 after selling out during the quarter.
  • HAP Trading sold 26,527 Amicus Therapeutics shares in Q4 2021, an estimated $296K.
  • HAP Trading first reported a position in Amicus Therapeutics in Q1 2017 and held it in 5 quarters.
  • HAP Trading's Amicus Therapeutics position peaked at $1.18M in Q4 2020.
  • 224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2021.

Based on HAP Trading's 13F filing for Q4 2021, filed 14 Feb 2022.